Skip to content

Drug interactions

Cyclosporin + Elranatamab

Severity: Moderate

Cyclosporin and Elranatamab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elranatamab triggers cytokine release, which can temporarily suppress CYP450 enzyme activity. This may raise exposure to cyclosporine, a narrow therapeutic index CYP3A4 substrate, and increase the risk of nephrotoxicity and neurotoxicity. The risk is highest during step-up dosing and around cytokine release syndrome episodes.

What this interaction means in plain words

Cyclosporin and Elranatamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cyclosporin belongs to Miscellaneous; Elranatamab belongs to Oncology.

Evidence level: Moderate

Why it happens

Cytokine-mediated downregulation of CYP3A4 activity during cytokine release syndrome reduces cyclosporine metabolism.

What to do

Monitor cyclosporine trough concentrations and renal function during step-up dosing and for about 14 days after, and during any CRS episode. Reduce the cyclosporine dose if levels or toxicity signs rise.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cyclosporin and Elranatamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cyclosporin with Elranatamab?

MediHelp rates the interaction as moderate. Cyclosporin and Elranatamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elranatamab triggers cytokine release, which can temporarily suppress CYP450 enzyme activity. This may raise exposure to cyclosporine, a narrow therapeutic index CYP3A4 substrate, and increase the risk of nephrotoxicity and neurotoxicity. The risk is highest during step-up dosing and around cytokine release syndrome episodes.

How serious is the interaction between Cyclosporin and Elranatamab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor cyclosporine trough concentrations and renal function during step-up dosing and for about 14 days after, and during any CRS episode. Reduce the cyclosporine dose if levels or toxicity signs rise.

What other medicines interact with Cyclosporin?

MediHelp also lists interactions of Cyclosporin with, for example, Adenovirus types 4 and 7 live, Aliskiren, Bcg vaccine live. The full list is on the Cyclosporin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in